How cost-effective is hepatitis C virus treatment for people who inject drugs?
How cost-effective is hepatitis C virus treatment for people who inject drugs?
复制标题
对于注射吸毒者来说，丙型肝炎病毒治疗的成本效益如何？
DOI：
10.1111/jgh.12113
复制
发表时间：
2013
影响因子：
4.1
通讯作者：
Martin N
中科院分区：
文献类型：
--
作者：
Martin N
本文讨论了慢性丙型肝炎病毒（HCV）是如何成为肝脏疾病的重要原因。在许多发达国家，如澳大利亚，大多数感染发生在注射毒品者中。还强调了丙型肝炎病毒治疗PWID的成本效益，特别是在澳大利亚。
The article discusses how chronic hepatitis C virus (HCV) is an important cause of liver disease. In many developed countries, such as Australia, the majority of infections are among people who inject drugs (PWID). Also highlighted is the cost-effectiveness of HCV treatment for PWID, particularly in Australia.